AntineoplasticsExanthema, rash and lack of efficacy: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2022年 / 1935卷 / 1期

关键词：

D O I：

10.1007/s40278-022-28854-3

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：59 / 59

相关论文

共 50 条

[31] Mogamulizumab/romidepsinInterface dermatitis drug rash and lack of efficacy: case report
Reactions Weekly, 2021, 1847 (1) : 311 - 311
[32] Alpelisib/metforminInterstitial lung disease, rash and lack of efficacy: case report
Reactions Weekly, 2023, 1946 (1) : 30 - 30
[33] Multiple drugsAcneiform rash, neutropenic incidents and lack of efficacy: case report
Reactions Weekly, 2025, 2042 (1) : 292 - 292
[34] Antineoplastics/epirubicinAdrenocorticotropic hormone deficiency, skin rash and lack of efficacy: case report
Reactions Weekly, 2022, 1895 (1) : 58 - 58
[35] AntineoplasticsSevere bacteraemia, skin rash and lack of efficacy in critical condition: case report
Reactions Weekly, 2021, 1836 (1) : 94 - 94
[36] Multiple drugsAnaphylaxis, drug-induced rash and lack of efficacy: case report
Reactions Weekly, 2024, 2035 (1) : 296 - 296
[37] Darbepoetin-alfa/thalidomideNeuropathy, skin rash and lack of efficacy: case report
Reactions Weekly, 2023, 1947 (1) : 148 - 148
[38] Multiple drugsPeripheral sensory neuropathy, cutaneous rash and lack of efficacy: case report
Reactions Weekly, 2021, 1845 (1) : 273 - 273
[39] Multiple drugsAcute hepatitis, severe skin rash and lack of efficacy: case report
Reactions Weekly, 2022, 1925 (1) : 326 - 326
[40] Antineoplastics/Folinic-acidAnaemia, skin rash and lack of efficacy: case report
Reactions Weekly, 2024, 2031 (1) : 44 - 44

← 1 2 3 4 5 →